Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-02
2008-12-02
Henley, III, Raymond J (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S556000
Reexamination Certificate
active
07459481
ABSTRACT:
This invention provides methods and compositions for inducing weight loss and maintaining optimum weight comprising administering an agent that stimulates carnitine palmitoyl transferase-1 (CPT-1) activity to the patient in need, including human patients. These methods do not require inhibition of fatty acid synthesis. In particular, this invention provides methods for development of therapeutics that selectively enhance fatty acid oxidation, increase energy production, and reduce adiposity while preserving lean mass, through the pharmacological stimulation of CPT-1 activity. In a preferred mode, the agent is administered in an amount sufficient to increase fatty acid oxidation. In another preferred mode, the agent is administered in an amount sufficient to antagonize malonyl CoA inhibition of CPT-1. In yet another preferred mode, the agent is administered in an amount sufficient to increase malonyl CoA level.
REFERENCES:
patent: 4434160 (1984-02-01), Jeretin et al.
patent: 5981575 (1999-11-01), Kuhajda et al.
patent: 6413545 (2002-07-01), Alviar et al.
patent: 2004/0161803 (2004-08-01), Corkey
patent: WO 99/07388 (1999-02-01), None
patent: WO 01/34145 (2001-05-01), None
patent: WO 01/60174 (2001-08-01), None
patent: WO 02/079501 (2002-10-01), None
Eaton, et al., Carnitine Palmitoyl Transferase I and the control of myocardial β-oxidation flux Biochemical Society, vol. 29, part 2, p. 245-250, 2001.
Karlic, et al., “Dietary L-carnitine Stimulates Carnitine Acltransferases in the Liver of Aged Rats”, The Journal of Histochemistry & Cytochemistry, vol. 50, No. 2, p. 205-212, 2002.
Loftus, et al., “Reduced Food Intake and Body Weight in Mice Treated with Fatty Acid Synthase Inhibitors”, Science, vol. 288, p. 2379-2381, Jun. 30, 2002.
Rahman, et al., “Effects of Conjugated Linoleic Acid on Serum Leptin Concentration, Body-Fat Accumulation, and β-Oxidation of Fatty Acid in OLETF Rats”, Nutrition, vol. 17, p. 385-390, 2001.
Kuhajda Francis P.
Landree Leslie E.
Ronnett Gabrielle
Thurpari Jagan N.
Henley, III Raymond J
Hunton & Williams LLP
The Johns Hopkins University School of Medicine Licensing And Te
LandOfFree
Stimulation of CPT-1 as a means to reduce weight does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stimulation of CPT-1 as a means to reduce weight, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stimulation of CPT-1 as a means to reduce weight will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4032166